177 related articles for article (PubMed ID: 1976361)
1. T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.
Champlin RE
Cancer Treat Res; 1990; 50():99-111. PubMed ID: 1976361
[TBL] [Abstract][Full Text] [Related]
2. T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemia.
Wiesneth M; Hertenstein B; Bunjes D; Schmeiser T; Arnold R; Heimpel H; Heit W
Eur J Haematol; 1988 Sep; 41(3):243-9. PubMed ID: 3053241
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation.
Champlin R; Gajewski J; Feig S; Giorgi J; Lyddane N; Lee K; Schmidt I; Winston D; Ho W; Reichert T
Transplant Proc; 1989 Feb; 21(1 Pt 3):2947-8. PubMed ID: 2495694
[No Abstract] [Full Text] [Related]
4. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
5. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
Butturini A; Gale RP
Bone Marrow Transplant; 1988 May; 3(3):185-92. PubMed ID: 3048485
[TBL] [Abstract][Full Text] [Related]
6. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.
Maraninchi D; Mawas C; Stoppa AM; Gaspard MH; Marit G; Van Ekthoven A; Reiffers J; Olive D; Hirn M; Delaage M
Bone Marrow Transplant; 1989 Mar; 4(2):147-50. PubMed ID: 2650783
[TBL] [Abstract][Full Text] [Related]
7. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
8. Immunohematological aspects of total body irradiation and bone marrow transplantation for the treatment of leukemia.
van Bekkum DW; Hagenbeek A
Radiother Oncol; 1990; 18 Suppl 1():30-6. PubMed ID: 2247647
[TBL] [Abstract][Full Text] [Related]
9. Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Champlin R; Ho W; Gajewski J; Feig S; Burnison M; Holley G; Greenberg P; Lee K; Schmid I; Giorgi J
Blood; 1990 Jul; 76(2):418-23. PubMed ID: 2142440
[TBL] [Abstract][Full Text] [Related]
10. T-cell depletion of HLA-identical transplants in leukemia.
Marmont AM; Horowitz MM; Gale RP; Sobocinski K; Ash RC; van Bekkum DW; Champlin RE; Dicke KA; Goldman JM; Good RA
Blood; 1991 Oct; 78(8):2120-30. PubMed ID: 1912589
[TBL] [Abstract][Full Text] [Related]
11. Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial.
Mitsuyasu RT; Champlin RE; Gale RP; Ho WG; Lenarsky C; Winston D; Selch M; Elashoff R; Giorgi JV; Wells J
Ann Intern Med; 1986 Jul; 105(1):20-6. PubMed ID: 3521427
[TBL] [Abstract][Full Text] [Related]
12. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
Champlin R
Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
[TBL] [Abstract][Full Text] [Related]
13. Results of four different protocols for prophylaxis against graft-versus-host disease.
Tollemar J; Ringdén O; Bäckman L; Janossy G; Lönnqvist B; Markling L; Philstedt P; Sundberg B
Transplant Proc; 1989 Feb; 21(1 Pt 3):3008-10. PubMed ID: 2650414
[No Abstract] [Full Text] [Related]
14. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH
Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
20. T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
Naparstek E; Or R; Nagler A; Cividalli G; Engelhard D; Aker M; Gimon Z; Manny N; Sacks T; Tochner Z
Br J Haematol; 1995 Mar; 89(3):506-15. PubMed ID: 7734348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
